By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



49 boulevard du Général Martial Valin

  Paris  75015  France
Phone: 33-0-1-45-58-76-00 Fax: 33-0-1-45-58-08-81


Key Statistics

Ownership: Public

Web Site: Onxeo
Symbol: ONXEO.PA


Company News
Monopar, Onxeo (ONXEO.PA) Ink Mucositis Deal Worth $108 Million 9/13/2017 7:17:19 AM
Onxeo (ONXEO.PA) Plunges After Liver Cancer Drug Fails Late-Stage Study 9/12/2017 5:50:07 AM
Onxeo Divests Two Non-Core Products In Oral Pathologies To Vectans Pharma 7/31/2017 12:19:50 PM
Onxeo Reports First-Half 2017 Results And Business Update 7/31/2017 10:04:35 AM
Onxeo Announces Positive Preclinical Proof Of Concept Results Confirming AsiDNA Activity via Systemic Administration 7/5/2017 8:54:53 AM
Onxeo Announces 10th Positive DSMB Recommendation To Continue Livatag Relive Phase III Trial In HCC 5/23/2017 10:17:25 AM
Clinigen And Onxeo Initiate Managed Access Programme For Belinostat In Europe For Patients With Peripheral T-Cell Lymphoma (PTCL) 5/11/2017 6:06:48 AM
Onxeo Announces Allowance Of U.S. Patent For Livatag In Hepatocellular Carcinoma 5/10/2017 12:27:05 PM
Onxeo: Q1 2017 Financial Information And Business Update 4/26/2017 11:24:55 AM
Onxeo: Publication Of 2016 Registration Document 4/26/2017 6:49:03 AM